The aim of the study was the development of new highly precise testing methods for early diagnosis of prostate cancer. For this purpose, the values of Ca/Al, Ca/B, Ca/Ba, Ca/Mn, Mg/Al, Mg/B, Mg/Ba, Mg/Mn, S/Al, S/B, S/Ba, S/Mn, Zn/Al, Zn/B, Zn/Ba, and Zn/Mn mass fraction ratios in normal (n=37), benign hypertrophic (n=32) and cancerous (n=60) human prostate gland were investigated using a combination of non-destructive and destructive methods: instrumental neutron activation analysis and inductively coupled plasma atomic emission spectrometry, respectively. Mean values ± standard error of mean (M ± SEM) for mass fraction ratios in the normal tissue were as follows Ca/Al 103 ± 21, Ca/B 4320 ± 805, Ca/Ba 2957 ± 577, Ca/Mn 2061 ± 325, Mg/Al 36.1 ± 4.1, Mg/B 1599 ± 239, Mg/Ba 1086 ± 227, Mg/Mn 776 ± 70, S/Al 319 ± 31, S/B 14749 ± 2166, S/Ba 9640 ± 1968, S/Mn 6991 ± 379, Zn/Al 41.3 ± 9.7, Zn/B 1974 ± 559, Zn/Ba 1003 ± 195, and Zn/Mn 875 ± 214, respectively. It was observed that in benign hypertrophic tissues the Ca/B, Mg/B, and S/B mass fraction ratios are lower than normal levels while the Mg/Al and Mg/Mn ratio are significantly higher. In cancerous tissue the values of all ratios investigated were significantly lower than in normal and benign hypertrophic prostate. It was shown that the Ca/Ba, Ca/Mn, Mg/Al, Mg/Ba, Zn/Al, Zn/B, and Zn/Ba mass fraction ratios are the most informative for a differential diagnosis among all investigated mass fraction ratios. Finally, we propose to use the (Ca/Ba)•(Mg/Al)•(Zn/Mn) and (Ca/Ba)•(Mg/Al)•(S/B)•(Zn/ Mn) multiplications of mass fraction ratios in a needle-biopsy core as the most informative indicators for distinguishing malignant from benign prostate. Sensitivity, specificity, and accuracy of these tests were 100-9%, 100-2%, and 100-2%, respectively. Further studies on larger number of samples are required to confirm our findings, to study the impact of the chemical element contents on prostate cancer etiology and to examine the long-term pathological outcome.